S1 Biopharma, an early-stage biopharmaceutical company, has announced its foray into male sexual health with S1P-205, the drug in development to treat Hypoactive Sexual Desire Disorder (HSDD) in males. With the development of S1P-205, the ...
Tags: S1 Biopharma, male sexual health, S1P-205, drug